Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06028009 · ClinicalTrials.gov registry record · NA

PRP Injections for Genitourinary Syndrome of Menopause

A NA study of Vaginal Atrophy and Postmenopausal Symptoms, sponsored by Medstar Health Research Institute.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06028009 is a NA study of Vaginal Atrophy and Postmenopausal Symptoms that is active but no longer recruiting, run by Medstar Health Research Institute. The registered enrollment target is 30 participants, below the 353-participant average among 9 other Vaginal Atrophy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06028009, a NA study of Vaginal Atrophy and Postmenopausal Symptoms, is active but no longer recruiting, sponsored by Medstar Health Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Platelet-rich plasma (PRP) is autologous blood which has been centrifuged to separate the supernatant resulting in a solution with high concentration of platelets. Injection of PRP stimulates cell growth and can has been proven safe and effective for uses in orthopedics, dermatology, and gynecology. Despite the relative paucity of data, the use of PRP as a therapy for sexual dysfunction and genitourinary symptoms in the setting of menopause has been patented as the O-Shot and V-Shot. This is a single-blinded randomized control trial to determine if PRP injections into the anterior vaginal wall improve sexual functioning in women diagnosed with the genitourinary syndrome of menopause (GSM) characterized by vaginal dryness/irritation.

Conditions Studied

Vaginal Atrophy Postmenopausal Symptoms Genitourinary Syndrome of Menopause Sexual Function Disturbances PRP

Interventions

  • PROCEDURE Injection of platelet-rich plasma
  • PROCEDURE Injection of saline

Study Locations (1)

District of Columbia

  • MedStar Lafayette Medical Centre - Washington D.C.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-03-01
Est. Completion 2026-04-30
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06028009

The ClinicalTrials.gov registry entry for NCT06028009 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 353-participant average among 9 other Vaginal Atrophy trials with a reported enrollment target (92% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Vaginal Atrophy appearing as the primary indexed condition, and to 2 interventions - of which Injection of platelet-rich plasma is the first listed.

NCT06028009 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06028009 about?

NCT06028009 is a clinical study titled "PRP Injections for Genitourinary Syndrome of Menopause". Platelet-rich plasma (PRP) is autologous blood which has been centrifuged to separate the supernatant resulting in a solution with high concentration of platelets. Injection of PRP stimulates cell growth and can has been proven safe and effective for uses in orthopedics, dermatology, and gynecology....

What is the current status of trial NCT06028009?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-03-01. Estimated completion is 2026-04-30.

What conditions does trial NCT06028009 study?

This clinical trial studies the following conditions: Vaginal Atrophy, Postmenopausal Symptoms, Genitourinary Syndrome of Menopause, Sexual Function Disturbances, PRP.

What interventions are being tested in trial NCT06028009?

The interventions under investigation include: Injection of platelet-rich plasma (PROCEDURE), Injection of saline (PROCEDURE).

Who is sponsoring clinical trial NCT06028009?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06028009 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vaginal Atrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Vaginal Atrophy

All registered trials for this condition

Postmenopausal Symptoms

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.